Which mutation in the FGFR3 gene is associated with thanatophoric dysplasia?
Thanatophoric dysplasia type I and II are neonatal lethal skeletal dysplasias caused by gain-of-function missense mutations in FGFR3 transmembrane or kinase domains, such as Arg248Cys, Tyr373Cys, Lys650Glu located in IgIII and kinase activation loop. These substitutions cause ligand-independent constitutive dimerization and activation of receptor tyrosine kinase, overactivating MAPK ERK and STAT1 pathways inhibiting chondrocyte proliferation and differentiation in growth plate, accelerating premature hypertrophy and apoptosis. Loss-of-function FGFR3 causes skeletal overgrowth tall stature opposite phenotype. Thus activating FGFR3 restricts endochondral bone growth demonstrating dosage sensitivity of RTK signaling in chondrogenesis.
Ref: Muenke & Schell, Trends Genetics: Activating FGFR3 mutations cause thanatophoric dysplasia via constitutive kinase activity.